izpis_h1_title_alt

Effect of electrochemotherapy on myogenesis of mouse C2C12 cells in vitro
ID Kranjc Brezar, Simona (Avtor), ID Medved, Ajda (Avtor), ID Matkovič, Urška (Avtor), ID Serša, Gregor (Avtor), ID Markelc, Boštjan (Avtor), ID Božič, Tim (Avtor), ID Jurdana, Mihaela (Avtor), ID Čemažar, Maja (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (6,17 MB)
MD5: 2BB1226260E890A5B3B5C3BE5F709E4B
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S156753942300124X Povezava se odpre v novem oknu

Izvleček
Electrochemotherapy (ECT) is a local ablative therapy for the treatment of different skin and subcutaneous tumors and certain tumors in internal organs. Skeletal muscle represents a major tumor-surrounding tissue, exposed to side effects of ECT. At the cellular level, side-effects of ECT on skeletal muscle and underlying mechanisms have not been examined yet. Thus, we aimed to determine the effect of ECT in the mouse muscle cell line C2C12 during in vitro myogenesis. We evaluated the electroporation efficiency and viability of C2C12 myotubes at increasing voltages (200–1300 V/cm) using propidium iodide (PI). Permeabilization of PI into the cells was voltage-dependent accounting up to 97 % efficiency at the highest voltage. High cell viability and myotube integrity were maintained until 4 days after electroporation. ECT with the cytostatic drugs bleomycin and cisplatin decreased the viability of C2C12 myoblasts and myotubes in a dose-dependent manner. However, myoblasts were more sensitive to ECT than myotubes. Increased secretion of IL-6, observed 3 days after ECT, confirming its effects on early myogenesis. Only minor effects of ECT were observed in treated myotubes. These results contribute to the safety profile of ECT in tumor treatment.

Jezik:Angleški jezik
Ključne besede:electroporation, electrochemotherapy, myogenesis, bleomycin, cisplatin, skeletal muscle
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:7 str.
Številčenje:Vol. 153, art. 108487
PID:20.500.12556/RUL-152845 Povezava se odpre v novem oknu
UDK:616-083
ISSN pri članku:1567-5394
DOI:10.1016/j.bioelechem.2023.108487 Povezava se odpre v novem oknu
COBISS.SI-ID:156727811 Povezava se odpre v novem oknu
Datum objave v RUL:08.12.2023
Število ogledov:216
Število prenosov:26
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Bioelectrochemistry
Založnik:Elsevier
ISSN:1567-5394
COBISS.SI-ID:2502484 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:elektroporacija, elektrokemoterapija, miogeneza

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0003
Naslov:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj